S1PR5 is essential for human natural killer cell migration toward sphingosine-1 phosphate - 11/01/18
![](/templates/common/images/mail.png)
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
The T.W. lab is supported by the Association pour la Recherche sur le Cancer, Agence Nationale de la Recherche, the European Research Council, Institut National de la Santé et de la Recherche Médicale, CNRS, Université de Lyon, and ENS de Lyon. Biogen also sponsored this study. |
|
Disclosure of potential conflict of interest: A. Drouillard's, A.-L. Mathieu's, A. Marçais's, and S. Viel's institutions received grants from Biogen, Inc, for this work. A. Belot's institution received a grant from Biogen, Inc, for this work and received payment for lectures from Novartis; he personally received board membership from Abbive and received travel expenses from Novartis and Octapharma. M. Mingueneau and K. Guckian are employees of Biogen, Inc. T. Walzer's institute received a grant from Biogen, Inc, for this work; payment for lectures from Novartis; and travel expenses from Octapharma. K. Guckian declares that he has no relevant conflicts of interest. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?